EXELA PHARMA SCIENCES

GANCICLOVIR

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

EXELA PHARMA SCIENCES

Ganciclovir HCPCS:

J1574

HCPCS Code Descriptor:

Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg

Category:

J Code

Ganciclovir NDCs:

51754-2500-03, 51754-2500-01

Primary Type:

Antiviral

Generic/Specialty Status:

Single-Source

Package Type:

Flex Cont

Route of Administration:

Intravenous

Ganciclovir CPT Codes:

Potential CPT administration codes for Ganciclovir can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

51754-2500-03, 51754-2500-01

About Ganciclovir:

GANCICLOVIR is a Antiviral drug manufactured by EXELA PHARMA SCIENCES and administered via the Intravenous route of administration. The J Code: J1574 is aligned to the drug GANCICLOVIR.

ACCESS PRICING AND MORE BY REGISTERING

J1574 Added Date:

January 1, 2023

J1574 Effective Date:

January 1, 2023

J1574 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ganciclovir billing and coding information.
Our team did not identify a source for Ganciclovir patient assistance information. Please reach out to our team if you feel that this is a mistake.
GANCICLOVIR prescribing information can be found at the link below:
Information regarding GANCICLOVIR’s side effects can be found at MedlinePlus